Someone you care about is unwell, and you want to be useful. You can look through what’s recruiting in Canada, keep what seems worth a second look, and send it to them or their doctor in one message.
Whether they follow any of it up is theirs to decide.
As you look, keep the trials that seem worth a second look. When you’re ready, they go to the person you’re thinking of — or to their doctor — as one plain-language note, in your words. Nothing is sent until you say so.
Whether they read it, or do anything with it, is entirely theirs. You don’t need their details to do any of this.
Not sure how to bring it up? A few things worth knowing first →
Explore this study →
One site, in Toronto
Official title: A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Breast Cancer · Genentech, Inc.
Get them matched to the best-fit trials
Answer a few questions and we'll find the closest matches.
Looking for the closest fit?
Get matched →Concord provides information only. Trial listings come from public registries, and whether anyone can take part is decided by the trial site and their own care team.